These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28798269)

  • 41. Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
    Ochoa-Figueroa MA; Uña-Gorospe J; Allende-Riera A; Cárdenas-Negro JC; Muñoz-Iglesias J; Cabello-García D; De Sequera-Rahola M; Martínez-Gimeno E
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):249-56. PubMed ID: 23067526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
    Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
    Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Shandal V; Kumar R
    BJU Int; 2010 Jul; 106(1):132-3. PubMed ID: 20553479
    [No Abstract]   [Full Text] [Related]  

  • 45. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH
    Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discussion of: Endoscopic and histopathological analysis of incidental focal colorectal
    Am J Surg; 2018 Mar; 215(3):382-383. PubMed ID: 29502656
    [No Abstract]   [Full Text] [Related]  

  • 48. A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
    Huang YY; Lee PI; Liu MC; Chen CC; Huang KC; Huang AT
    Clin Nucl Med; 2015 Oct; 40(10):e465-9. PubMed ID: 26204213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer.
    Simó M; Lomeña F; Setoain J; Pérez G; Castellucci P; Costansa JM; Setoain-Quinquer J; Doménech-Torné F; Carrió I
    Nucl Med Commun; 2002 Oct; 23(10):975-82. PubMed ID: 12352596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A surgical perspective on positron emission tomography.
    Gulec SA
    J Surg Oncol; 2007 May; 95(6):443-6. PubMed ID: 17221861
    [No Abstract]   [Full Text] [Related]  

  • 51. FDG-PET in colorectal cancer.
    de Geus-Oei LF; Ruers TJ; Punt CJ; Leer JW; Corstens FH; Oyen WJ
    Cancer Imaging; 2006 Oct; 6(Spec No A):S71-81. PubMed ID: 17114081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
    Imdahl A; Reinhardt MJ; Nitzsche EU; Mix M; Dingeldey A; Einert A; Baier P; Farthmann EH
    Langenbecks Arch Surg; 2000 Mar; 385(2):129-34. PubMed ID: 10796051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
    Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of local recurrence of colorectal cancer: the role of PET/CT.
    Bamba Y; Itabashi M; Kameoka S
    Abdom Imaging; 2011 Jun; 36(3):322-6. PubMed ID: 20661560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup.
    Zervos EE; Badgwell BD; Burak WE; Arnold MW; Martin EW
    Surgery; 2001 Oct; 130(4):636-43; discussion 643-4. PubMed ID: 11602894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
    de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
    J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
    Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
    J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.
    Chen LB; Tong JL; Song HZ; Zhu H; Wang YC
    World J Gastroenterol; 2007 Oct; 13(37):5025-9. PubMed ID: 17854148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Importance of FDG-PET/computed tomography in colorectal cancer].
    Kleiner S; Weber W
    Radiologe; 2019 Sep; 59(9):812-819. PubMed ID: 31428810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.